Literature DB >> 6202955

Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.

C S Raine.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6202955

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


× No keyword cloud information.
  74 in total

1.  Age dependence of clinical and pathological manifestations of autoimmune demyelination. Implications for multiple sclerosis.

Authors:  M E Smith; N L Eller; H F McFarland; M K Racke; C S Raine
Journal:  Am J Pathol       Date:  1999-10       Impact factor: 4.307

2.  Chronic remitting experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis.

Authors:  E Zapryanova; D Deleva; M Bakalska; N Filchev
Journal:  Neurosci Behav Physiol       Date:  1999 Jan-Feb

Review 3.  Regulation of oligodendrocyte development.

Authors:  D M Orentas; R H Miller
Journal:  Mol Neurobiol       Date:  1998-12       Impact factor: 5.590

4.  Axon reactions precede demyelination in experimental models of multiple sclerosis.

Authors:  E Zapryanova; O S Sotnikov; S S Sergeeva; D Deleva; A Filchev; B Sultanov
Journal:  Neurosci Behav Physiol       Date:  2004-05

Review 5.  Statins as potential therapeutic agents in multiple sclerosis.

Authors:  Olaf Stüve; Thomas Prod'homme; Sawsan Youssef; Shannon Dunn; Oliver Neuhaus; Martin Weber; Hans-Peter Hartung; Lawrence Steinman; Scott S Zamvil
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

Review 6.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

Review 7.  Restoring the balance between disease and repair in multiple sclerosis: insights from mouse models.

Authors:  Robert H Miller; Sharyl L Fyffe-Maricich
Journal:  Dis Model Mech       Date:  2010-07-20       Impact factor: 5.758

8.  Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.

Authors:  D M Karussis; U Vourka-Karussis; D Lehmann; H Ovadia; R Mizrachi-Koll; A Ben-Nun; O Abramsky; S Slavin
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

9.  Localization of interferon-gamma and Ia-antigen in T cell line-mediated experimental autoimmune encephalomyelitis.

Authors:  G Stoll; S Müller; B Schmidt; P van der Meide; S Jung; K V Toyka; H P Hartung
Journal:  Am J Pathol       Date:  1993-06       Impact factor: 4.307

10.  Physical mapping of the human and mouse MOG gene at the distal end of the MHC class Ib region.

Authors:  D Pham-Dinh; E P Jones; G Pitiot; B Della Gaspera; P Daubas; J Mallet; D Le Paslier; K Fischer Lindahl; A Dautigny
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.